F.D.A. Reverses Decision and Agrees to Review Moderna’s Flu Vaccine
Moderna held further discussions with regulators and announced that the [...]
Moderna held further discussions with regulators and announced that the [...]
A political movement cannot survive on spite alone.
With $55 billion earmarked to bolster its U.S. operations, Johnson [...]
In a deal with Theriva Biologics potentially worth as much [...]
Only a couple of months ago, Sensei Biotherapeutics was laying [...]
Unnatural Products is proving to be a natural at securing [...]
Shaped primarily by discussions with Gen Xers and older millennials, [...]
Boehringer Ingelheim is discarding an inhaled gene therapy designed to [...]
The company is confident that results from a head-to-head trial [...]
Japan-based cell therapy company Innovacell is planning to end a [...]